Kickstand Ventures’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Kickstand Ventures's BMY Position: Q2 2026 in Review
Kickstand Ventures increased its Bristol-Myers Squibb (BMY) stake by 1.6% in Q2 2026, buying an estimated $3.73K and bringing the position to 4,240 shares worth $244K. The position accounts for 0.04% of the portfolio, ranked #137.
Kickstand Ventures first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $253K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Kickstand Ventures held 4,240 shares of Bristol-Myers Squibb worth $244K as of Q2 2026.
- Kickstand Ventures bought 65 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.73K.
- Bristol-Myers Squibb made up 0.04% of Kickstand Ventures's portfolio in Q2 2026, its #137 holding.
- Kickstand Ventures first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Kickstand Ventures's Bristol-Myers Squibb position peaked at $253K in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Kickstand Ventures's 13F filing for Q2 2026, filed 30 Jul 2026.